Brief: Calian Wins Contract To Support Clinical Trial For Zyus Life Sciences’ Lead Drug Product Candidate
Feb 20 (Reuters) - Calian Group Ltd CGY.TO :
* CALIAN WINS CONTRACT TO SUPPORT CLINICAL TRIAL FOR ZYUS
LIFE
SCIENCES’ LEAD DRUG PRODUCT CANDIDATE
* CALIAN GROUP LTD: CONTRACT TO SUPPORT PHASE 2 CLINICAL
TRIAL OF
ZYUS LIFE SCIENCE'S TRICHOMYLIN SOFTGEL CAPSULES
Source text for Eikon: ID:nGNXbY9xsg
Further company coverage: CGY.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Calian
See all newsBrief: Calian Completes Sale Of U.S. Commercial It Business To Trace3
Brief: Calian Completes Acquisition Of Galaxy Broadband
Canada Research Roundup: Bird Construction, Magellan Aerospace Corporation, Terravest Industries
Canada's Calian Q3 profit beats on higher space, defence offerings demand
Brief: Calian UK Secures CAD$296 Million, 15-Year British Army Training Agreement